The impact of resveratrol on ocular microcirculation and structural changes in an experimental model of ischemia-reperfusion of the retina

Purpose. To study the effect of antioxidant resveratrol on hemodynamics and morphological changes in the ocular structure of rats with retinal ischemia-reperfusion injury. Material and Methods. The experimental study was performed on 50 Wistar rats. The animals were divided into two groups: group I (20 intact animals) and, group II (30 animals who received resveratrol per os for one month. We modeled unilateral ischemia-reperfusion of the eye by increasing IOP to the level of 110 mm Hg within 30 minutes, pumping air into the anterior chamber. Group I was further divided into subgroup IA (10 animals undergoing ischemia-reperfusion modeling of one eye and IB (control) which consisted of 10 intact rats. All animals of group II kept receiving resveratrol for 1 month and underwent the modeling of ischemia-reperfusion of the eye, whereupon the administration of reservatrol was resumed for another month. Ocular blood flow was estimated using power Doppler (PD) and pulsed-wave spectral Doppler ultrasonography before ischemia-reperfusion and 3, 7, 30 days after it. The eyeball was enucleated on the 3 rd, 7th, or 30 th day in the post-ischemic period of the experiment to enable a pathomorphological study. Results. The signs of ischemic damage of the anterior and posterior segments of the eye were reduced in rats who received resveratrol during the pre-ischemic (within 30 days) and the post-ischemic follow up period (30 days). We noted a statistically significant increase of peak systolic velocity (Vsyst), increase of end diastolic velocity (Vdiast) and decreased resistance index (RI) in the central retinal artery and short posterior ciliary arteries of rats that were treated with resveratrol as compared to the respective values found in rats with ischemia-reperfusion of the retina who were not given resveratrol. A histopathological examination revealed areas with intact retinal layers in rats who received resveratrol for a long period (1-2 months). Conclusions. An improvement of ocular blood flow and a neuroprotective effect was found in rats with ischemia-reperfusion who received resveratrol // Russian Ophthalmological Journal, 2016; 3: 66-74. doi: 10.21516/2072-0076-2016-9-3-66-74.

ишемия-реперфузия сетчатки, глазной кровоток, энергетическое картирование, ресвератрол, ischemia-reperfusion of the retina, ocular blood flow, Power Doppler, resveratrol

1. Курышева Н. И. Глаукомная оптическая нейропатия. Москва: МЕДпресс-информ; 2006.

2. Нероев В.В., Колчин А.А., Зуева М.В. и др. Изменение функциональной активности сетчатки и гемодинамики глаза у пациентов с тяжелыми стадиями диабетической ретинопатии. Российский офтальмологический журнал. 2014; 7(3): 19-26.

3. Нероев В.В., Зуева М.В., Цапенко И.В. и др. Ишемические аспекты патогенеза заболеваний сетчатки. Российский офтальмологический журнал. 2010; 3 (1): 42-49.

4. Janáky M., Grósz A., Tóth E., Benedek K., Benedek G. Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG. Doc. Ophthalmol. 2007; 114(1): 45-51.

5. Hudges W.F. Quantification of ischemic damage in the retina. Exp Eye Res. 1991; 53(5): 573-82.

6. Нечипуренко Н.И., Пашковская И.Д., Мусиенко Ю.И. Основные патофизиологические механизмы ишемии головного мозга. Медицинские новости; 2008; 1: 7-13.

7. Киселёва Т.Н., Чудин А.В. Экспериментальное моделирование ишемического поражения глаза. Вестник РАМН. 2014; 11-12: 97-103.

8. Prasad S.S., Kojic L., Wen Y.H., et al. Retinal gene expression after central retinal artery ligation: effects of ischemia and reperfusion. Inv. Ophthalmol. Vis. Sci. 2010; 51(12): 6207-19.

9. Buchi E.R., Suivaizdis I., Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Ophthalmologica. 1991; 203(3): 138-47.

10. Daugeliene L., Niwa M., Hara A., et al. Transient ischemic injury in the rat retina caused by trombotic occlusion-thrombolytic reperfusion. Inv. Ophthalmol. Vis. Sci. 2000; 41(9): 2743-7.

11. Masuzawa K., Jesmin S., Maeda S., et al. A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1. Exp. Biol. Med. (Maywood). 2006; 231(6): 1085-9.

12. Flower R.W., Patz A. The effect of hyperbaric oxygenation on retinal ischemia. Ophthalmology and Visual Science. 1971; 10(8):605-616.

13. Peachey N.S., Green D.J., Ripps H. Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye. Invest. Ophthalm. Vis. Science. 1993; 34(1): 58-65.

14. Lagrèze W.A., Müller-Velten R., Feuerstein T.J. The neuroprotective properties of gabapentin-lactam. Graefe’s Arch Clin Exp Ophthalmol. 2001; 239: 845-9.

15. Osborne N.N., Larsen A.K. Antigens associated with specific retinal cells are affected by ischemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem. Int. 1996; 29(3): 263-70.

16. Roth S., Pietrzyk Z. Blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci, 1994; 35: 3209-17.

17. Matsuura K., Kawai Y. Effects of hypothermia and aging on postischemic reperfusion in rat eyes. Jpn. J. Physiol. 1998; 48(1): 9-15.

18. Ishihara M., Nakano T., Ohama E., Kawai Y. Postischemic reperfusion in the eyes of young and aged rats. Jpn. J. Physiol. 2000; 50(1):125-32.

19. Шабельникова А.С., Кашуба А.С., Пересыпкина А.А. и др. Протективное действие эритропоэтина при моделировании ишемии-реперфузии сетчатки. Научные ведомости белгородского государственного университета. Серия: Медицина. Фармация. 2014; 182(11-1):109-12.

20. Li C., Wang L., Huang K., Zheng L. Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol. Invest Ophthalmol Vis Sci. 2012; 53(6):3241-9.

21. Vin A.P., Hu H., Zhai Y., et al. Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury. Exp Eye Res. 2013; 108: 72-5.

22. Liu X. Q., Wu B.J., Pan W.H., et al. Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther. 2013; 29(1): 33-40.

23. Huang W., Li G., Qiu J., Gonzalez P., Challa P. Protective effects of resveratrol in experimental retinal detachment. PLoS One. 2013; 8(9):e75735.

24. Kim Y.H., Kim Y.S., Kang S.S., Cho G.J., Choi W.S. Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase II activity in diabetic mouse retina. Diabetes. 2010; 59(7):1825-35.

25. Marshall S., Milligan A., Yates R. Experimental techniques and anesthesia in the rat and mouse. ANZCCART News. 1944; 7(1): 1-4.

26. Гнездилова А.В., Ганьшина Т.С., Мирзоян Р.С. ГАМК-ергический механизм цереброваскулярного эффекта мексидола. Экспериментальная и клиническая фармакология. 2010; 73(10): 11-3.

27. Bertuglia S., Malandrino S., Colantuoni A. Effect of Vaccinium myrtillus anthocyanosides on ischaemia reperfusion injury in hamster cheek pouch microcirculation. Pharmacol Res. 1995; 31 (3-4):183-7.

28. Киселева Т.Н. Роль антоцианозидов в коррекции нарушений микроциркуляции и гемодинамики глаза при офтальмопатологии. Российский офтальмологический журнал. 2013; 6(1): 8-10.

29. Дзугкоев С.Г., Дзугкоева Ф.С. Некоторые механизмы корригирующего влияния эндогенных антиоксидантов на метаболические и гемодинамические нарушения при экспериментальном сахарном диабете. Фундаментальные исследования. 2011; 11(3):499-502.

30. Zhihua H., Liangdong L., Xiao L., Fang C., Jing Z. Effect of 3(')-daidzein sulfonic sodium on the anti-oxidation of retinal ischemia/reperfusion injury in rats. Adv Exp Med Biol. 2010; 664: 585-91.

31. Ozden S., Müftüoğlu S., Tatlipinar S., et al. Protective effects of antithrombin III on retinal ischemia/reperfusion injury in rats: a histopathologic study. Eur J Ophthalmol. 2005; 15(3):367-73.